{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:02:56Z","timestamp":1789084976077,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008307","name":"Promedica Foundation","doi-asserted-by":"publisher","award":["1515\/M"],"award-info":[{"award-number":["1515\/M"]}],"id":[{"id":"10.13039\/501100008307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011824","name":"EAACI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["848101005"],"award-info":[{"award-number":["848101005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jaci.2024.06.023","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:55:30Z","timestamp":1721480130000},"page":"1333-1338.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9115-5683","authenticated-orcid":false,"given":"Margot E.","family":"Starrenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Bel Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Buergi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Tan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk E.M.","family":"Nouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette J.T.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Caspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcbeccel","family":"Akdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G.M.A.","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-6688","authenticated-orcid":false,"given":"Willem","family":"van de Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.06.023_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.06.023_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jid.2020.07.006","article-title":"Which way do we go? Complex interactions in atopic dermatitis pathogenesis","volume":"141","author":"Patrick","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.06.023_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2021.04.006","article-title":"Cytokine-skewed Tfh cells: functional consequences for B cell help","volume":"42","author":"Olatunde","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2024.06.023_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/jdv.14066","article-title":"Cyclosporine A\u00a0for severe atopic dermatitis in children. Efficacy and safety in a retrospective study of 63 patients","volume":"31","author":"Hern\u00e1ndez-Mart\u00edn","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2024.06.023_bib5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaad.2020.06.054","article-title":"Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial","volume":"83","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2024.06.023_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2024.06.023_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2023.05.011","article-title":"B cells: the many facets of B cells in allergic diseases","volume":"152","author":"Satitsuksanoa","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.06.023_bib9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/all.14684","article-title":"Biology and dynamics of B cells in the context of IgE-mediated food allergy","volume":"76","author":"Satitsuksanoa","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0944","article-title":"Type 2-polarized memory B cells hold allergen-specific IgE memory","volume":"16","author":"Koenig","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2024.06.023_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/all.15601","article-title":"IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases","volume":"78","author":"Aranda","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0673","article-title":"CD23+IgG1+ memory B cells are poised to switch to pathogenic IgE production in food allergy","volume":"16","author":"Ota","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2024.06.023_bib13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.aau2599","article-title":"High-affinity allergen-specific human antibodies cloned from single IgE B cell transcriptomes","volume":"362","author":"Croote","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaci.2024.06.023_bib14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/cea.13954","article-title":"Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases","volume":"51","author":"Hamilton","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib15","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jid.2021.01.022","article-title":"Early and long-term effects of dupilumab treatment on circulating T-cell functions in patients with moderate-to-severe atopic dermatitis","volume":"141","author":"Bakker","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.06.023_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/all.15576","article-title":"Comprehensive analysis of human IL-4 receptor subunits shows compartmentalization in steady state and dupilumab treatment","volume":"78","author":"Heeb","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0192-0561(93)90020-Y","article-title":"IL-4 receptor expression by SAC-activated B-lymphocytes: its role in B-cell proliferation and the effect of cyclosporine (CsA), prednisolone and verapamil","volume":"15","author":"Degiannis","year":"1993","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.jaci.2024.06.023_bib19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/eji.1830200536","article-title":"Inhibition of interleukin 4 receptor expression on human lymphoid cells by cyclosporin","volume":"20","author":"Foxwell","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2024.06.023_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5021\/ad.2010.22.1.9","article-title":"The efficacy and safety of long-term oral cyclosporine treatment for patients with atopic dermatitis","volume":"22","author":"Haw","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaci.2024.06.023_bib21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","article-title":"Enteric-coated mycophenolate sodium versus cyclosporin A\u00a0as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2024.06.023_bib22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/all.12416","article-title":"Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern","volume":"69","author":"Boos","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/all.15591","article-title":"Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients","volume":"78","author":"Spekhorst","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.06.023_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaci.2016.03.042","article-title":"CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells","volume":"139","author":"Selb","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.06.023_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0091-6749(80)90026-3","article-title":"Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease","volume":"66","author":"Wittig","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.06.023_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/all.15576","article-title":"Comprehensive analysis of human IL-4 receptor subunits shows compartmentalization in steady state and dupilumab treatment","volume":"78","author":"Heeb","year":"2023","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492400736X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492400736X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:05:05Z","timestamp":1777475105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492400736X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S009167492400736X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.06.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}